Member Info for Timster

Hold onto your hats

Nice, energy and that's the reality.

The current trial is making a difference to people's lives.

All we care about is the share price .

They've probably lost it or its failed...

Could be more

Cohort 7 completion (but then how does the study run parallel)

FDA approval for 2 weekly dosing

1a data

And that's what we know is definitely coming.

As I'm bored waiting for my tyres (which did appear on the 21st), here's some sujood classics, all wrong other than the interim results rns which is a true miracle that noone could have foreseen

10th October

Find your glasses

Put them by the bedside

You will need them for a morning read.

Night

28 September

Here comes this week's thunderball....

7(am)

22nd September

Rub your hands together .....

I predict a massive RNS before the Investor Presentation on Thursday the 28th.

End of Q4 Al said in an interview so that's in December

Avacta must be fuming twice now they have had to move RNSs because the insiders have spilled the beans, his lordship last week and now the main man Sujood

Ian is sujoods second account.

Or the prophets son

Ian is sujoods second account.

Or the prophets son

2 months in.

The shortest cohort was 2 months

A guess!!!!!!!

He's never been wrong hummm (apart from always) his 100% record is fully intact.

Must be running late, never been wrong.....

eggy also forgets that it told us that it used to be ndn and ndn was confirmed as eggy.

come on eggy your brain is scrambled your **** at this now, it's been sad and upsetting seeing you deteriorate.

One last push it's Q4.

Bring back Terry.

Lol is that your direct competition concerns fulfilled.

Ps that's radiotherapy.

The inner sanctum trying to quell the excitement for tomorrow.

Only Nadine Dorries knows the truth....

The platform article posted earlier was also very interesting. We have a working platform that can deliver toxic drugs directly to fap rich tumours.

I just bought 2 tyres from etyre, when could the garage fit?? That's right 21st...... It's no coincidence...

Saying this in regulatory news

"Dr Alastair Smith, Chief Executive of Avacta Group plc commented:

"I believe that we are on the verge of a paradigm shift in how chemotherapy is delivered to cancer patients.

The safety and initial efficacy signals emerging from the data in the AVA6000 Phase 1 study are very encouraging indeed. The pre|CISIONTM platform is doing exactly what it was designed to do - target the release of active chemotherapy to the tumour tissue, sparing healthy tissues and improving the safety and tolerability of the drug whilst delivering potentially superior efficacy."

Then delivering average data with an apology they forgot to consider arthritis.

Not going to happen!